Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-04 1:54 pm Purchase | 13G | Viking Therapeutics Inc. VKTX | VANGUARD GROUP INC | 10,167,614 9.170% | 4,785,710 (+88.92%) | View |
| 2024-10-18 12:26 pm Sale | 13G | Viking Therapeutics Inc. VKTX | STATE STREET CORP STT | 4,666,157 4.200% | -1,066,833 (-18.61%) | View |
| 2024-08-07 4:10 pm Sale | 13G | Viking Therapeutics Inc. VKTX | BlackRock Inc. BLK | 5,463,979 4.900% | -2,141,888 (-28.16%) | View |
| 2024-02-14 10:13 am Sale | 13G | Viking Therapeutics Inc. VKTX | VIKING GLOBAL INVESTORS LP | 5,145,112 5.100% | -713,420 (-12.18%) | View |
| 2024-02-13 5:17 pm Purchase | 13G | Viking Therapeutics Inc. VKTX | VANGUARD GROUP INC | 5,381,904 5.380% | 5,381,904 (New Position) | View |
| 2024-02-09 10:05 am Purchase | 13G | Viking Therapeutics Inc. VKTX | FMR LLC | 15,004,340 14.999% | 4,081,593 (+37.37%) | View |
| 2024-01-26 11:49 am Purchase | 13G | Viking Therapeutics Inc. VKTX | BlackRock Inc. BLK | 7,605,867 7.600% | 6,178,646 (+432.91%) | View |
| 2024-01-24 1:24 pm Purchase | 13G | Viking Therapeutics Inc. VKTX | STATE STREET CORP STT | 5,732,990 5.730% | 5,486,148 (+2222.53%) | View |
| 2024-01-12 4:26 pm Sale | 13G | Viking Therapeutics Inc. VKTX | MILLENNIUM MANAGEMENT LLC | 403,556 0.400% | -4,425,644 (-91.64%) | View |
| 2023-11-02 4:30 pm Purchase | 13G | Viking Therapeutics Inc. VKTX | VIKING GLOBAL INVESTORS LP | 5,858,532 5.900% | 5,858,532 (New Position) | View |
| 2023-04-10 09:37 am Purchase | 13G | Viking Therapeutics Inc. VKTX | FMR LLC | 10,922,747 11.418% | 8,736,380 (+399.58%) | View |
| 2023-03-30 4:08 pm Sale | 13D | Viking Therapeutics Inc. VKTX | LIGAND PHARMACEUTICALS INC LGND | 3,616,077 4.600% | -2,449,003 (-40.38%) | View |
| 2023-02-14 5:28 pm Sale | 13G | Viking Therapeutics Inc. VKTX | ArrowMark Colorado Holdings LLC | 15,931 0.020% | -7,044,872 (-99.77%) | View |
| 2023-02-09 4:30 pm Sale | 13D | Viking Therapeutics Inc. VKTX | LIGAND PHARMACEUTICALS INC LGND | 6,065,080 7.900% | -1,274,303 (-17.36%) | View |
| 2023-02-03 3:36 pm Sale | 13G | Viking Therapeutics Inc. VKTX | STATE STREET CORP STT | 246,842 0.320% | -3,878,725 (-94.02%) | View |
| 2023-01-03 4:51 pm Purchase | 13G | Viking Therapeutics Inc. VKTX | MILLENNIUM MANAGEMENT LLC | 4,829,200 6.300% | 4,829,200 (New Position) | View |
| 2022-07-08 4:57 pm Sale | 13G | Viking Therapeutics Inc. VKTX | BlackRock Inc. BLK | 1,427,221 1.800% | -3,692,269 (-72.12%) | View |
| 2022-02-14 2:51 pm Sale | 13G | Viking Therapeutics Inc. VKTX | ArrowMark Colorado Holdings LLC | 7,060,803 9.030% | -1,446,987 (-17.01%) | View |
| 2022-02-11 9:23 pm Sale | 13G | Viking Therapeutics Inc. VKTX | STATE STREET CORP STT | 4,125,567 5.270% | -946,989 (-18.67%) | View |
| 2022-02-03 4:41 pm Sale | 13G | Viking Therapeutics Inc. VKTX | BlackRock Inc. BLK | 5,119,490 6.500% | -196,847 (-3.70%) | View |